Bausch Health Companies (TSE:BHC) Trading 5.2% Higher - What's Next?

Key Points

• Bausch Health Companies Inc. saw its shares increase by 5.2% to trade at C$10.38, marking a significant rise from its previous close of C$9.87.
• The stock trading volume surged to 604,900 shares, a 63% increase compared to the average session volume.
• Insider transactions revealed that director John Paulson purchased 1,782,030 shares at an average cost of C$8.14, culminating in a total investment of approximately C$14.5 million.

Bausch Health Companies Inc. (TSE:BHC - ) shares traded up 5.2% during mid-day trading on Friday . The company traded as high as C$10.74 and last traded at C$10.38. 604,900 shares were traded during mid-day trading, an increase of 63% from the average session volume of 371,612 shares. The stock had previously closed at C$9.87.

Bausch Health Companies Stock Performance

The business has a fifty day simple moving average of C$8.62 and a 200-day simple moving average of C$8.43. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of -1,831.94. The firm has a market cap of C$3.08 billion, a P/E ratio of -17.33, a P/E/G ratio of 0.21 and a beta of 0.77.

Insider Buying and Selling at Bausch Health Companies

In related news, Director John Paulson purchased 1,782,030 shares of Bausch Health Companies stock in a transaction dated Friday, June 13th. The stock was purchased at an average cost of C$8.14 per share, for a total transaction of C$14,501,803.73. Insiders acquired 3,553,401 shares of company stock worth $27,087,675 in the last ninety days. 11.28% of the stock is owned by company insiders.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.